{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262944458450304.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.7326/0003-4819-146-12-200706190-00007"}},{"identifier":{"@type":"URI","@value":"https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-146-12-200706190-00007"}},{"identifier":{"@type":"URI","@value":"https://www.acpjournals.org/doi/full-xml/10.7326/0003-4819-146-12-200706190-00007"}}],"dc:title":[{"@value":"Meta-analysis: Antithrombotic Therapy to Prevent Stroke in Patients Who Have Nonvalvular Atrial Fibrillation"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262944458450306","@type":"Researcher","foaf:name":[{"@value":"Robert G. Hart"}],"jpcoar:affiliationName":[{"@value":"From the University of Texas Health Science Center, San Antonio, Texas, and Mayo Clinic Scottsdale, Scottsdale, Arizona."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944458450305","@type":"Researcher","foaf:name":[{"@value":"Lesly A. Pearce"}],"jpcoar:affiliationName":[{"@value":"From the University of Texas Health Science Center, San Antonio, Texas, and Mayo Clinic Scottsdale, Scottsdale, Arizona."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944458450304","@type":"Researcher","foaf:name":[{"@value":"Maria I. Aguilar"}],"jpcoar:affiliationName":[{"@value":"From the University of Texas Health Science Center, San Antonio, Texas, and Mayo Clinic Scottsdale, Scottsdale, Arizona."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00034819"},{"@type":"EISSN","@value":"15393704"},{"@type":"PISSN","@value":"http://id.crossref.org/issn/00034819"}],"prism:publicationName":[{"@value":"Annals of Internal Medicine"}],"dc:publisher":[{"@value":"American College of Physicians"}],"prism:publicationDate":"2007-06-19","prism:volume":"146","prism:number":"12","prism:startingPage":"857","prism:endingPage":"867"},"reviewed":"false","dc:rights":["https://www.acpjournals.org/journal/aim/text-and-data-mining"],"url":[{"@id":"https://www.acpjournals.org/doi/pdf/10.7326/0003-4819-146-12-200706190-00007"},{"@id":"https://www.acpjournals.org/doi/full-xml/10.7326/0003-4819-146-12-200706190-00007"}],"createdAt":"2013-04-12","modifiedAt":"2025-02-10","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360002216047109120","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Design and Rationale of the RELAXED (Recurrent Embolism Lessened by rivaroxaban, an Anti-Xa agent, of Early Dosing for acute ischemic stroke and transient ischemic attack with atrial fibrillation) Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360004236437342208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prior Direct Oral Anticoagulant Therapy is Related to Small Infarct Volume and No Major Artery Occlusion in Patients With Stroke and Non‐Valvular Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011144819549952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The impact of surgical left atrial appendage amputation/ligation on stroke prevention in patients undergoing off-pump coronary artery bypass grafting"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168788044160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparative effectiveness of oral anticoagulants in everyday practice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168790008576","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168849028224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Stroke Severity and Outcomes in Patients With Newly Diagnosed Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360013168880046464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706959897984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Overview of oral antithrombotic treatment in elderly patients with atrial fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285708441412864","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Greater nighttime blood pressure variability is associated with left atrial enlargement in atrial fibrillation patients with preserved ejection fraction"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709542379648","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Editorial comment on ‘A novel approach indirectly comparing benefit: risk across oral antithrombotic therapies in patients with atrial fibrillation’. Are the evidences of current dose-adjusted anticoagulation with warfarin stroke prevention for patients with atrial fibrillation sufficient enough to compare with newly developed non-vitamin K oral anticoagulants?"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285709555265152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Oral anticoagulants usage in Japanese patients aged 18–74 years with non-valvular atrial fibrillation: a retrospective analysis based on insurance claims data"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643766621312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD‐AF Registry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165984350720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Persistence of non‐vitamin K antagonist oral anticoagulant use in Japanese patients with atrial fibrillation: A single‐center observational study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565168096947456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD‐AF and treated with vitamin K antagonists"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182240164992","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Safety and efficacy of contemporary catheter ablation for atrial fibrillation patients with a history of cardioembolic stroke in the era of direct oral anticoagulants"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182281802368","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Secondary Prevention of Stroke with Warfarin in Patients with Nonvalvular Atrial Fibrillation: Subanalysis of the J-RHYTHM Registry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567182281891072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567184519147776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of creatinine clearance on outcomes in patients with non-valvular atrial fibrillation: a subanalysis of the J-RHYTHM Registry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567186391930112","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cilostazol Ameliorates Warfarin-Induced Hemorrhagic Transformation After Cerebral Ischemia in Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092799479680","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A randomized comparison of two direct oral anticoagulants for patients undergoing cardiac ablation with a contemporary warfarin control arm"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118832316288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prior direct oral anticoagulant dosage and outcomes in patients with acute ischemic stroke and non-valvular atrial fibrillation: A sub-analysis of PASTA registry study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360588380606876672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"<scp>CHA<sub>2</sub>DS<sub>2</sub></scp>‐<scp>VASc</scp> score and prior oral anticoagulant use on endovascular treatment for acute ischemic stroke"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846643659318144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pericardial Endoscopy–Guided Left Atrial Appendage Ligation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657216855552","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Evaluation of safety and efficacy of periprocedural use of rivaroxaban and apixaban in catheter ablation for atrial fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657317525504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Nrf2 activator ameliorates hemorrhagic transformation in focal cerebral ischemia under warfarin anticoagulation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848657459677440","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Non-valvular atrial fibrillation patients with low CHADS2 scores benefit from warfarin therapy according to propensity score matching subanalysis using the J-RHYTHM Registry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848661367068800","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Total Thrombus‐Formation Analysis System (T‐TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360849941839261184","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical benefits and risks of antithrombotic therapy in patients with atrial fibrillation with comorbidities – A report from the CHART-2 Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567497355776","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360853567803635584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Residual risks of ischaemic stroke and systemic embolism among atrial fibrillation patients with anticoagulation: large-scale real-world data (F-CREATE project)"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593718469248","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"GARFIELD-AF: A Worldwide Prospective Registry of Patients With Atrial Fibrillation at Risk of Stroke"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593780064000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Development of imaging-based risk scores for prediction of intracranial haemorrhage and ischaemic stroke in patients taking antithrombotic therapy after ischaemic stroke or transient ischaemic attack: a pooled analysis of individual patient data from cohort studies"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861286493307136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Prognostic Impact of a History of Cancer and Atrial Fibrillation in Antithrombotic Therapy for Chronic Heart Failure"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861707367918592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Impact of Cerebral Microbleeds in Stroke Patients with Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1360865816808951168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A cost-effectiveness analysis of remote monitoring after pacemaker implantation for bradycardia in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1360869856039250048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Simple risk scoring using sinus rhythm electrocardiograms predicts the incidence of atrial fibrillation in the general population"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694366888037504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Structural heart intervention for prevention of embolic and hemorrhagic stroke: The new field of neurocardiology"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204274553984","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pharmacological properties and clinical efficacy of apixaban （Eliquis<sup>®</sup>）"},{"@language":"ja","@value":"経口FXa阻害薬アピキサバン（エリキュース<sup>®</sup>）の薬理学的特性と臨床効果"},{"@value":"新薬紹介総説 経口FXa阻害薬アピキサバン(エリキュース)の薬理学的特性と臨床効果"},{"@language":"ja-Kana","@value":"シンヤク ショウカイ ソウセツ ケイコウ FXa ソガイヤク アピキサバン(エリキュース)ノ ヤクリガクテキ トクセイ ト リンショウ コウカ"},{"@value":"Pharmacological properties and clinical efficacy of apixaban （Eliquis^|^#174;）"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204430674304","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Recent Progress in Antithrombotic Therapy for Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204450181888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"血栓を防ぐ（後編）：脳梗塞の抗凝固療法"},{"@language":"en","@value":"Role of anticoagulation for ischemic stroke patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204640071168","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The trend in antithrombotic therapy for cardioembolic stroke due to non-valvular atrial fibrillation"},{"@language":"ja","@value":"非弁膜症性心房細動に起因した心原性脳塞栓症発症時の抗血栓療法の状況に関する検討"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204771881216","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"心房細動症例の抗凝固療法におけるブコローム併用の現状とワルファリン投与量―J-RHYTHM Registryからの報告―"},{"@language":"en","@value":"Status of Bucolome Use and Warfarin Dose in Anticoagulation Therapy in Patients with Atrial Fibrillation--A Report from the J-RHYTHM Registry--"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204773443072","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"心原性脳塞栓症予防のパラダイムシフト"},{"@language":"en","@value":"A paradigm shift of the prevention of cardiogenic cerebral embolism"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204774390912","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"実臨床での心房細動管理における抗凝固薬の役割と今後の展開"},{"@language":"en","@value":"Role and Future Development of Novel Oral Anticoagulants for Managing Atrial Fibrillation in Clinical Practice"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205025157632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cardiovascular disease in the elderly: Management of atrial fibrillation and chronic heart failure"},{"@language":"ja","@value":"4．高齢者の心血管疾患：心房細動と慢性心不全の管理"},{"@value":"高齢者の心血管疾患 : 心房細動と慢性心不全の管理"},{"@language":"ja-Kana","@value":"コウレイシャ ノ シンケッカン シッカン : シンボウ サイドウ ト マンセイ シンフゼン ノ カンリ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205102359040","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Atrial Fibrillation and Anticoagulation Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205103800320","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antithrombotic Therapy in Atrial Fibrillation  - Evaluation and Positioning of New Oral Anticoagulant Agents -"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205107693312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age"},{"@value":"Rivaroxaban vs. Warfarin in Japanese Patients With Non-Valvular Atrial Fibrillation in Relation to Age : Insight From J-ROCKET AF"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205108093568","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Research and the Development of Medical Therapeutics"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205108324480","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Prognostic Impact of Atrial Fibrillation and New Risk Score of Its Onset in Patients at High Risk of Heart Failure　― A Report From the CHART-2 Study ―"},{"@value":"Prognostic impact of atrial fibrillation and new risk score of its onset in patients at high risk of heart failure—a report from the CHART-2 Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205108517504","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Oral Anticoagulation in Japanese Patients With Atrial Fibrillation"},{"@value":"Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation : Meta-Analysis"},{"@value":"Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants vs. Warfarin in Japanese Patients With Atrial Fibrillation"},{"@value":"Efficacy and safety of non-vitamin K antagonist oral anticoagulants vs. warfarin in Japanese patients with atrial fibrillation—meta-analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205108558464","@type":"Article","resourceType":"エディトリアル(editorial)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Incidence of Ischemic Stroke in Japanese Patients With Atrial Fibrillation Not Receiving Anticoagulation Therapy"},{"@value":"EDITORIAL : Is Anticoagulant Therapy Unnecessary for Lower-Risk Japanese Patients With Atrial Fibrillation? : Lessons From the SAMURAI-NVAF and BAT Studies"},{"@value":"Incidence of Ischemic Stroke in Japanese Patients With Atrial Fibrillation Not Receiving Anticoagulation Therapy : Pooled Analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry"},{"@value":"Is Anticoagulant Therapy Unnecessary for Lower-Risk Japanese Patients With Atrial Fibrillation?"},{"@value":"Incidence of ischemic stroke in Japanese patients with atrial fibrillation not receiving anticoagulation therapy—pooled analysis of the Shinken Database, J-RHYTHM Registry, and Fushimi AF Registry."}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205108668928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Left Atrial Appendage Thrombi Formation in Japanese Non-Valvular Atrial Fibrillation Patients During Anticoagulation Therapy　― Warfarin vs. Direct Oral Anticoagulants ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205109004288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Significance of Non-Vitamin K Antagonist Oral Anticoagulants in the Management of Atrial Fibrillation"},{"@value":"FOCUS REVIEWS ON ARRHYTHMIA : Clinical Significance of Non-Vitamin K Antagonist Oral Anticoagulants in the Management of Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205109027712","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation　– Results of the J-RHYTHM Registry 2 –"},{"@value":"LATE BREAKING COHORT STUDY (JCS 2016) : Beneficial Effect of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Nonvalvular Atrial Fibrillation : Results of the J-RHYTHM Registry 2"},{"@value":"Beneficial effect of non-vitamin K antagonist oral anticoagulants in patients with nonvalvular atrial fibrillation—results of the J-RHYTHM Registry 2"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205180110720","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Model-based Dose Selection for Phase III Rivaroxaban Study in Japanese Patients with Non-valvular Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205367991296","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"<b>Clinical Outcomes and Anticoagulant Intensity in Japanese Nonvalvular Atrial Fibrillation Patients ≥65 Years of Age with a CHADS<sub>2</sub> Score 0-1 and Taking Warfarin</b>"},{"@value":"<b>Clinical Outcomes and Anticoagulant Intensity in Japanese Nonvalvular Atrial Fibrillation Patients &ge;65 Years of Age with a CHADS<sub>2</sub> Score 0-1 and Taking Warfarin</b>"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001206431786112","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"Noninvasive Surrogate Markers to Predict Thrombogenesis in Patients with Nonvalvular Atrial Fibrillation"},{"@language":"en","@value":"Noninvasive Surrogate Markers to Predict Thrombogenesis in Patients with Nonvalvular Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001277396116736","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Guidelines for Atrial Fibrillation Treatment to Avoid Stroke Should Be Established for Each Region/Ethnicity"},{"@value":"Guideline-Adherent Treatment for Stroke and Death in Atrial Fibrillation Patients From UK and Japanese AF Registries"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001288097934976","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"III．Evidence-based medicine：診療現場でのプロブレムの解決法"},{"@language":"en","@value":"III. evidence-based medicine: How to solve the problems in clinical practice"},{"@value":"Evidence-based medicine : 診療現場でのプロブレムの解決法"},{"@language":"ja-Kana","@value":"Evidence-based medicine : シンリョウ ゲンバ デ ノ プロブレム ノ カイケツホウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390004222615842048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cost-Effectiveness of Obstructive Sleep Apnea Screening and Treatment Before Catheter Ablation for Symptomatic Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390011030550455168","@type":"Article","resourceType":"letter","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk　― Reply ―"},{"@value":"JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias"},{"@value":"JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk"},{"@value":"<scp>JCS</scp>/<scp>JHRS</scp> 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679426896896","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"血栓を識る（前編）：脳梗塞と一過性脳虚血発作の病型分類"},{"@language":"en","@value":"Etiologic classification of ischemic stroke and transient ischemic attack"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679427552768","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Antithrombotic therapy for atherothrombotic disease"},{"@language":"ja","@value":"動脈硬化性疾患の抗血栓療法"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679427969664","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Anticoagulation for atrial fibrillation"},{"@value":"心房細動に対する抗凝固療法"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679452964096","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Trend of Prevalence of Atrial Fibrillation and use of Oral Anticoagulation Therapy in Patients With Atrial Fibrillation in South Korea (2002–2013)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679748381312","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"心房細動患者に対する抗凝固療法の新展開"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679748551424","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"1．心房細動に対するワルファリン療法における日本人の至適INR―J-RHYTHM Registryからの報告―"},{"@language":"en","@value":"The Optimal Intensity of Warfarin Therapy in Japanese Patients with Atrial Fibrillation --A Report from the J-RHYTHM Registry--"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679749650304","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"抗血栓療法のＲｅａｌ　ｗｏｒｌｄと経口Ｎｅｗ　ａｎｔｉｃｏａｇｕｌａｎｔの展望"},{"@language":"en","@value":"Real world of antithrombotic therapy and perspective of new oral anticoagulant for patients with nonvalvular AF"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679750876288","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"我が国で用いられているプロトロンビン時間国際標準比（ＩＮＲ）測定用試薬の国際感度指数（ＩＳＩ）値とその問題点―Ｊ‐ＲＨＹＴＨＭ　Ｒｅｇｉｓｔｒｙからの検討―"},{"@language":"en","@value":"Present Status and Problems of International Sensitivity Index (ISI) on the Measurement of International Normalized Ratio of Prothrombin Time (INR)  ."}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679847328640","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Significant Impairment of Left Atrial Function in Patients with Cardioembolic Stroke Caused by Paroxysmal Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679847337600","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Quality of Wafarin Control Affects the Incidence of Stroke in Elderly Patients with Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679853381376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Features of Ischemic Stroke during Treatment with Dabigatran: An Association between Decreased Severity and a Favorable Prognosis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680002396416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Anticoagulant therapy with dabigatran in elderly patients ≥80 years of age with atrial fibrillation"},{"@language":"ja","@value":"80歳を超える高齢者に対するダビガトランによる抗凝固療法の検討"},{"@language":"ja-Kana","@value":"80サイ オ コエル コウレイシャ ニ タイスル ダビガトラン ニ ヨル コウギョウコ リョウホウ ノ ケントウ"},{"@value":"Anticoagulant therapy with dabigatran in elderly patients ^|^ge;80 years of age with atrial fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680078750336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Efficacy and Safety of Dabigatran vs. Warfarin in Patients With Atrial Fibrillation  - Sub-Analysis in Japanese Population in RE-LY Trial -"},{"@value":"Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation —Sub-analysis in Japanese population in RE-LY trial"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680083341312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Interventional Closure of the Left Atrial Appendage for Stroke Prevention"},{"@value":"Interventional Closure of the Left Atrial Appendage for Stroke Prevention : Experience of a High-Volume Center"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680083664128","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Short-Term Safety and Plasma Concentrations of Edoxaban in Japanese Patients With Non-Valvular Atrial Fibrillation and Severe Renal Impairment"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680084275968","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Comparison of the 2MACE and TIMI-AF Scores for Composite Clinical Outcomes in Anticoagulated Atrial Fibrillation Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680085292160","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Cardiological Aspects of Stroke Prevention"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680085584768","@type":"Article","resourceType":"エディトリアル(editorial)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Optimal Anticoagulation for Patients With Atrial Fibrillation　— Benefits for Reducing Stroke Severity —"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680155941632","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Confirmation of Model-based Dose Selection for a Japanese Phase III Study of Rivaroxaban in Non-valvular Atrial Fibrillation Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680201052544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Effects of Smoking on Ischemic Stroke, Intracranial Hemorrhage, and Coronary Artery Events in Japanese Patients With Non-Valvular Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680221586688","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"New Insights into Anticoagulation in Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681421128192","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"3. Atrial Fibrillation and Embolism; Prognosis and Prevention"},{"@language":"ja","@value":"3．心房細動と塞栓症：予知と予防"},{"@value":"教育講演 心房細動と塞栓症--予知と予防"},{"@language":"ja-Kana","@value":"キョウイク コウエン シンボウ サイドウ ト ソクセンショウ ヨチ ト ヨボウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282681424891392","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"4．高齢者心房細動における新しい脳梗塞予防"},{"@language":"en","@value":"4. Latest Stroke Prevention in Elderly Patients with Atrial Fibrillation"},{"@value":"高齢者心房細動における新しい脳梗塞予防"},{"@language":"ja-Kana","@value":"コウレイシャ シンボウ サイドウ ニ オケル アタラシイ ノウ コウソク ヨボウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282763015868544","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"非弁膜性心房細動症例における直接作用型経口抗凝固薬の使用実態調査"},{"@language":"en","@value":"Survey of Direct-Acting Oral Anticoagulants for Non-Valvular Atrial Fibrillation"},{"@language":"ja-Kana","@value":"ヒベンマクセイ シンボウ サイドウ ショウレイ ニ オケル チョクセツ サヨウガタ ケイコウ コウギョウコヤク ノ シヨウ ジッタイ チョウサ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282763120479744","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Prestroke Aspirin Use is Associated with Clinical Outcomes in Ischemic Stroke Patients with Atherothrombosis, Small Artery Disease, and Cardioembolic Stroke"}]},{"@id":"https://cir.nii.ac.jp/crid/1390287142241521920","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Evidence and Challenges for Left Atrial Appendage Management"},{"@language":"ja","@value":"左心耳閉鎖の evidence と課題"}]},{"@id":"https://cir.nii.ac.jp/crid/1390290846617475456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Evaluation of the Feasibility and Efficacy of a Novel Device for Screening Silent Atrial Fibrillation (MYBEAT Trial)"},{"@value":"Can a Patch Electrocardiographic Device Be a Leading Actor for Detecting Atrial Fibrillation? : Diversifying Electrocardiographic Monitoring Devices"},{"@value":"Can a patch electrocardiographic device be a leading actor for detecting atrial fibrillation?—diversifying electrocardiographic monitoring devices"}]},{"@id":"https://cir.nii.ac.jp/crid/1390302259652521728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Five-year outcomes in patients with ischemic stroke or transient ischemic attack after widespread use of direct oral anticoagulants"},{"@language":"ja","@value":"直接経口抗凝固薬普及後の脳梗塞または一過性脳虚血発作患者の5年転帰"}]},{"@id":"https://cir.nii.ac.jp/crid/1390304704716204928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Secondary Prevention of Stroke in Patients with Non-Valvular Atrial Fibrillation and Advanced Chronic Kidney Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390569382247414400","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Atrial Fibrillation After Ischemic Stroke Detected by Chest Strap-Style 7-Day Holter Monitoring and the Risk Predictors: EDUCATE-ESUS"}]},{"@id":"https://cir.nii.ac.jp/crid/1390570242645918208","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Inhibitory Effect of Rivaroxaban on Atrial Arrhythmogenesis via Protease-Activated Receptor 2 Pathway"},{"@value":"Activated Factor X Signaling Pathway via Protease-Activated Receptor 2 Is a Novel Therapeutic Target for Preventing Atrial Fibrillation"}]},{"@id":"https://cir.nii.ac.jp/crid/1390572632983995904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Evidence and Challenges in Left Atrial Appendage Management"}]},{"@id":"https://cir.nii.ac.jp/crid/1390576834608976640","@type":"Article","resourceType":"紀要論文(departmental bulletin paper)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The Usefulness of Heart Rate Variability Spectral Analysis in Detecting Covert Atrial Fibrillation among Patients with Cryptogenic Stroke"},{"@value":"The Usefulness of Heart Rate Variability Spectrum Analysis in Detecting Covert Atrial Fibrillation among Patients with Cryptogenic Stroke"}]},{"@id":"https://cir.nii.ac.jp/crid/1390578005888460672","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Causes of Death in Elderly Patients With Non-Valvular Atrial Fibrillation　― Results From the ANAFIE Registry ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390579709066943872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Under-Dose Prescription of Direct Oral Anticoagulants in Japanese Elderly Patients　― Are One Fifth of the Prescriptions All “Inappropriate”? ―"},{"@value":"Relationship Between Direct Oral Anticoagulant Doses and Clinical Outcomes in Elderly Patients With Non-Valvular Atrial Fibrillation : ANAFIE Registry Sub-Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1390583502303166464","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"A Novel Risk Score for Major Bleeding in Japanese Patients with Non-Valvular Atrial Fibrillation: The J-RISK AF Study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390585172429134592","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"わが国の後期高齢者健康診査における12誘導心電図検査実施の現状と課題"},{"@language":"en","@value":"Status and Issues Regarding the Implementation of a 12-lead Electrocardiogram During Medical Checkups for Individuals Aged 75 Years and Older in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1390852182141580416","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"原因不明とされる脳梗塞症例の塞栓源探索に対する血管内視鏡を用いた大動脈破綻プラーク観察の有効性に関して"}]},{"@id":"https://cir.nii.ac.jp/crid/1390854717690356224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"10-Year Trends of Antithrombotic Therapy Status and Outcomes in Japanese Atrial Fibrillation Patients　― The Fushimi AF Registry ―"}]},{"@id":"https://cir.nii.ac.jp/crid/1390865596627664512","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Improvement in Atrial Fibrillation Detection by Pulse Checking of Patients with Non-Cardioembolic Stroke in Rehabilitation Hospitals: The ESCORT Study"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.7326/0003-4819-146-12-200706190-00007"},{"@type":"CROSSREF","@value":"10.1161/jaha.118.009507_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-13-0828_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-16-0066_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2133/dmpk.dmpk-12-rg-109_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-11-0304_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-14-0459_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2169/naika.97.2237_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.3143/geriatrics.51.218_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.3143/geriatrics.51.350_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5105/jse.30.174_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5105/jse.30.80_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2491/jjsth.23.8_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.arr.2018.10.006_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5105/jse.33.195_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-14-1342_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5105/jse.34.157_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2169/naika.103.1798_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-19-0934_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.jjcc.2020.04.007_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.ijcard.2019.09.022_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/jjcsc.30.0_35_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2185/jjrm.67.58_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1136/heartjnl-2020-318420_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1182/bloodadvances.2020003560_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.3389/fneur.2021.666491_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1007/s00380-022-02027-w_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.17264/stmarieng.13.127_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1007/s00380-016-0915-x_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.4020/jhrs.27.186_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1038/s41440-018-0060-2_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1093/ehjcvp/pvu017_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1093/fampra/cmz016_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-13-1324_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-14-0942_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circrep.cr-20-0074_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2188/jea.je20160149_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-21-0157_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1254/fpj.142.247_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2491/jjsth.24.30_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5105/jse.31.225_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-17-0039_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2491/jjsth.28.267_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1111/jth.15415_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-22-0023_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1002/joa3.12714_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5551/jat.64842_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1272/jnms.jnms.2024_91-612_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.joa.2015.04.004_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1111/bjh.14084_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1093/ehjqcco/qcx032_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1161/strokeaha.113.001183_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-14-1131_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-14-1378_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-16-1089_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2133/dmpk.dmpk-12-rg-034_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-11-0191_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.nbd.2016.02.001_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-11-0402_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5551/jat.58420_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.49.3795_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5551/jat.7153_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.3995/jstroke.33.551_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5105/jse.33.25_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-16-0759_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.4264/numa.75.2_88_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-20-1061_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1007/s10840-020-00732-y_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.jns.2022.120163_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-20-1212_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-22-0614_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-001988_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5551/jat.65186_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5105/jse.45.15_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1002/acn3.52217_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1161/circinterventions.114.001610_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1161/jaha.115.002744_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.jjcc.2016.03.014_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.thromres.2015.06.009_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.49.3580_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1536/ihj.16-228_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.jstrokecerebrovasdis.2017.04.030_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-15-0319_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.3999/jscpt.46.191_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5761/atcs.ra.21-00040_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0240859_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1136/heartjnl-2020-317299_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2169/naika.106.2545_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5551/jat.46136_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2217/fca-2020-0014_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/s1474-4422(21)00024-7_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1002/ehf2.13941_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-23-0143_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1002/ana.26642_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.jjcc.2023.06.003_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1038/s41598-024-60219-y_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.54.4948_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.jstrokecerebrovasdis.2016.01.035_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.jstrokecerebrovasdis.2015.11.020_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-17-1318_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.2491/jjsth.28.335_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.5105/jse.32.202_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.1016/j.jjcc.2016.10.001_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"},{"@type":"CROSSREF","@value":"10.4326/jjcvs.50.1.xxxvi_references_DOI_AQZcvuX5I12KHD4wHwc8ZIKYUjk"}]}